We have cloned the promoter for the human third component of complement (C3) gene and have identified sequences involved in its regulation during the acute-phase response. A construct linking 199 bp of the C3 promoter to the firefly luciferase gene was found to be very responsive to interleukin-1 (IL-1) and modestly responsive to interleukin-6 (IL-6) by transfection analysis in the human hepatoma line Hep3B2. Simultaneous treatment with the two cytokines showed a strong synergy between the actions of the two molecules. A 58-bp fragment (-127 to -70 bp) was shown by 5' and 3' deletional mutagenesis to contain cis-acting elements that mediated both the IL-1 response and the IL-l-plus-IL-6 synergistic response of this promoter. When coupled to a heterologous promoter, this fragment enabled the synergistic induction by IL-1 plus transcription factor CCAAT/enhancer-binding protein (C/EBP), which included the IL-i-responsive elementlike sequence. No differences were seen between the footprints generated by using extracts from unstimulated and IL-i-stimulated Hep3B2 cells. However, gel retardation analyses revealed two IL-i-specific bands. The data suggest that the induction by IL-1 is mediated by a factor belonging to the family of C/EBP-related proteins.The third component of complement (C3) is the pivotal component of the complement system in that it functions in both the classical and alternative pathways of complement activation. It has been estimated that 90% of serum C3 is liver derived (2), with the remainder contributed from a wide range of cell types, including fibroblasts (26, 42), monocytes (7,46), macrophages (7, 12), and some epithelial cells (43,44). C3 is a member of the class of molecules termed acute-phase reactants, proteins produced primarily by the liver whose synthesis is increased in response to tissue injury, infection, or other inflammatory stimuli (reviewed in references 3 and 13). We have used the human hepatoma line Hep3B2 to mimic the acute-phase reaction in vitro (8). These cells increase the synthesis of C3 and other acute-phase proteins in response to conditioned media from stimulated peripheral blood mononuclear cells. Nuclear run-on experiments using Hep3B2 and other hepatoma lines have shown these increases to reflect, at least in part, altered transcription of many of the acute-phase genes, including the C3 gene (our unpublished results; 19).A number of cytokines have been implicated in the induction of the acute-phase reaction (3,13). These include interleukin-1 (IL-1) (8,40,49), interleukin-6 (IL-6) (18, 40), tumor necrosis factor (8, 38, 49), transforming growth factor P, (32), and hepatocyte-stimulating factors I to III (4). No single cytokine, however, has yet been shown to induce the increased synthesis of the full spectrum of acute-phase * Corresponding author.reactants. C3 falls into the subset of acute-phase reactants including mouse serum amyloid A (22, 35) that are primarily responsive to IL-1. Nuclear run-on experiments performed in our laboratory (9) have shown the IL-1...